Literature DB >> 19467363

An initial investigation of the orbitofrontal cortex hyperactivity in obsessive-compulsive disorder: exaggerated representations of anticipated aversive events?

Stefan Ursu1, Cameron S Carter.   

Abstract

Orbitofrontal cortical (OFC) dysfunction has been repeatedly involved in obsessive-compulsive disorder, but the precise significance of this abnormality is still unclear. Current neurocognitive models propose that specific areas of the OFC contribute to behavioral regulation by representing the anticipated affective value of future events. This leads to the hypothesis that these OFC areas are hyperactive in patients, reflecting ruminative preoccupation with future aversive events. In experimental situations, such hyperactivity should be triggered by negative affect in response to high likelihood of events such as the conflict between simultaneously active incompatible responses, which can potentially lead to poor task performance. We tested this hypothesis by examining fMRI indices of brain activity of 15 OCD patients and 15 matched controls. Subjects were scanned while performing a cognitive task which involved responding to cues and subsequent probes, and some of the probes elicited response conflict. Relative to controls, the lateral OFC of patients was specifically hyperactive to cues associated with high proportion of subsequent high-conflict probes. The level of OFC hyperactivity correlated directly with the severity of anxiety symptoms. These results support the hypothesis that OCD is characterized by exaggerated OFC representations of anticipated aversive events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19467363      PMCID: PMC2688401          DOI: 10.1016/j.neuropsychologia.2009.03.018

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  31 in total

1.  Abstract reward and punishment representations in the human orbitofrontal cortex.

Authors:  J O'Doherty; M L Kringelbach; E T Rolls; J Hornak; C Andrews
Journal:  Nat Neurosci       Date:  2001-01       Impact factor: 24.884

2.  Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control.

Authors:  A W MacDonald; J D Cohen; V A Stenger; C S Carter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

3.  Neuroimaging research and the neurobiology of obsessive-compulsive disorder: where do we go from here?

Authors:  S L Rauch
Journal:  Biol Psychiatry       Date:  2000-02-01       Impact factor: 13.382

4.  Neural activity in the human brain relating to uncertainty and arousal during anticipation.

Authors:  H D Critchley; C J Mathias; R J Dolan
Journal:  Neuron       Date:  2001-02       Impact factor: 17.173

5.  Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder.

Authors:  S Saxena; A L Brody; K M Maidment; J J Dunkin; M Colgan; S Alborzian; M E Phelps; L R Baxter
Journal:  Neuropsychopharmacology       Date:  1999-12       Impact factor: 7.853

Review 6.  Conflict monitoring and decision making: reconciling two perspectives on anterior cingulate function.

Authors:  Mattew M Botvinick
Journal:  Cogn Affect Behav Neurosci       Date:  2007-12       Impact factor: 3.282

7.  Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression.

Authors:  K Alptekin; B Degirmenci; B Kivircik; H Durak; B Yemez; E Derebek; Z Tunca
Journal:  Psychiatry Res       Date:  2001-07-01       Impact factor: 3.222

8.  Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study.

Authors:  Scott L Rauch; Lisa M Shin; Darin D Dougherty; Nathaniel M Alpert; Alan J Fischman; Michael A Jenike
Journal:  Neuropsychopharmacology       Date:  2002-11       Impact factor: 7.853

9.  Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.

Authors:  A L Brody; S Saxena; L A Fairbanks; S Alborzian; H A Demaree; K M Maidment; L R Baxter
Journal:  J Clin Psychiatry       Date:  2000-05       Impact factor: 4.384

10.  Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder.

Authors:  Jun Soo Kwon; Jae-Jin Kim; Dong Woo Lee; Jae Sung Lee; Dong Soo Lee; Myung-Sun Kim; In Kyoon Lyoo; Maeng Je Cho; Myung Chul Lee
Journal:  Psychiatry Res       Date:  2003-01-20       Impact factor: 3.222

View more
  10 in total

1.  Structural evidence for involvement of a left amygdala-orbitofrontal network in subclinical anxiety.

Authors:  Karen Blackmon; William B Barr; Chad Carlson; Orrin Devinsky; Jonathan DuBois; Daniel Pogash; Brian T Quinn; Ruben Kuzniecky; Eric Halgren; Thomas Thesen
Journal:  Psychiatry Res       Date:  2011-07-30       Impact factor: 3.222

2.  Pathways for emotions and attention converge on the thalamic reticular nucleus in primates.

Authors:  Basilis Zikopoulos; Helen Barbas
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

Review 3.  Neuroimaging of cognitive brain function in paediatric obsessive compulsive disorder: a review of literature and preliminary meta-analysis.

Authors:  Silvia Brem; Tobias U Hauser; Reto Iannaccone; Daniel Brandeis; Renate Drechsler; Susanne Walitza
Journal:  J Neural Transm (Vienna)       Date:  2012-06-08       Impact factor: 3.575

4.  Altered activation in fronto-striatal circuits during sequential processing of conflict in unmedicated adults with obsessive-compulsive disorder.

Authors:  Rachel Marsh; Guillermo Horga; Nidhi Parashar; Zhishun Wang; Bradley S Peterson; H Blair Simpson
Journal:  Biol Psychiatry       Date:  2013-03-13       Impact factor: 13.382

5.  Neuregulin 3 Signaling Mediates Nicotine-Dependent Synaptic Plasticity in the Orbitofrontal Cortex and Cognition.

Authors:  Luyi Zhou; Miranda L Fisher; Robert D Cole; Thomas J Gould; Vinay Parikh; Pavel I Ortinski; Jill R Turner
Journal:  Neuropsychopharmacology       Date:  2017-11-07       Impact factor: 7.853

Review 6.  Validity of Quinpirole Sensitization Rat Model of OCD: Linking Evidence from Animal and Clinical Studies.

Authors:  Ales Stuchlik; Dominika Radostová; Hana Hatalova; Karel Vales; Tereza Nekovarova; Jana Koprivova; Jan Svoboda; Jiri Horacek
Journal:  Front Behav Neurosci       Date:  2016-10-26       Impact factor: 3.558

7.  The safety and efficacy of transcranial direct current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder: a randomized, double-blind, sham-controlled, clinical trial.

Authors:  Sadegh Yoosefee; Man Amanat; Mona Salehi; Seyed Vahid Mousavi; Jamshid Behzadmanesh; Victoria Safary; Ali Yoonesi; Bahman Salehi
Journal:  BMC Psychiatry       Date:  2020-11-30       Impact factor: 3.630

Review 8.  Neuromodulation of OCD: A review of invasive and non-invasive methods.

Authors:  Alexandra Kammen; Jonathon Cavaleri; Jordan Lam; Adam C Frank; Xenos Mason; Wooseong Choi; Marisa Penn; Kaevon Brasfield; Barbara Van Noppen; Stuart B Murray; Darrin Jason Lee
Journal:  Front Neurol       Date:  2022-08-09       Impact factor: 4.086

9.  Aberrant orbitofrontal cortical activation interferes with encoding of Pavlovian fear conditioning.

Authors:  Chung-Fu Sun; Chun-Hui Chang
Journal:  Front Behav Neurosci       Date:  2022-08-22       Impact factor: 3.617

10.  Resting-state functional connectivity between fronto-parietal and default mode networks in obsessive-compulsive disorder.

Authors:  Emily R Stern; Kate D Fitzgerald; Robert C Welsh; James L Abelson; Stephan F Taylor
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.